Leiden, The Netherlands, February 6, 2008. Biotech company Pharming Group NV (“Pharming”) (NYSE Euronext: PHARM) today announced that it will participate in the therapeutic workshop on Hereditary Angioedema (HAE) at the BIO CEO & Investor Conference 2008 (February 11- 13, 2008) in New York.
